Abstract
Introduction
Metastatic lesions of the oral cavity are extremely rare, accounting for approximately 1% of all malignant oral tumors. Renal cell carcinoma (RCC) is the third most common tumor that metastasizes to the head and neck region (1) . Approximately 15% of RCCs metastasize to the head and neck region (2, 3) . The nose and paranasal sinuses are most commonly affected, followed by the oral cavity (1) . The most common sites of oral soft tissues for metastases are attached gingiva followed by the tongue (4) . A primary tumor of the kidney metastasizing to the tongue is very unusual (5) . The prognosis for patients with lingual metastasis of RCC is poor. Treatment of tongue metastasis is usually palliative and aims to provide patient comfort by means of pain relief and prevention of bleeding and infection.
Surgical excision is recommended as the primary treatment, with emphasis on preservation of tongue structure and function. This can be followed by adjuvant radiotherapy to achieve local control of disease. Chemotherapeutic agents including fluoropyrimidines together with biological agents such as interferon-α can offer a palliative benefit in some patients with RCC (5) . Newer agents such as sorafenib and sunitinib have been shown to improve progression-free survival in metastatic RCC (6, 7) . We discuss a case of RCC presenting as a clear-cell tumor in the tongue.
Case Report
An 80-year old male presented with a swelling on the dorsal surface of the tongue which had been removed superficially once before by a dentist and recurred again after several months. Intraorally, a 1×1-cm oval-shaped, reddish, sessile, slightly indurated and painless swelling was observed on the midline of the dorsal surface of the tongue which had started bleeding over 5 months previously. The patient had hypertension, and there were no similar lesions in other parts of his body. A biopsy was taken from the lesion and submitted for histopathologic examination with suspicions of a reactive lesion.
Gross examination
An oval-shaped, creamy-to-brownish, elastic soft tissue mass, covered by epithelium, was submitted for histopathologic examination. The lesion measured 10×7×5 mm in size.
Microscopic examination
A malignant epithelial proliferation of mostly clear cells was observed that was located as a relatively well-circumscribed nodular mass below the parakeratinized stratified squamous epithelium of the tongue mucosa (Fig. 1) . These cells were arranged in a nested pattern and separated by fibrous septa (Fig. 2) . Neoplastic cells were polygonal, had pleomorphic vesicular to hyperchromatic nuclei, were located mostly eccentrically, and had clear and sometimes eosinophilic cytoplasm with sharply outline cell membranes (Fig. 3 ). There was a rich capillary vascular network at the surface. 
Diagnosis
According to histopathologic examination, primary and metastatic clear-cell tumors were suspected. Systemic examination of the patient revealed that there had not been any similar lesion in other parts of his body. The patient-stated past medical history had no notable features. Because of this, the possibility of a metastatic clear-cell tumor was dismissed. The tumor was initially thought to be a primary tongue cancer with salivary gland neoplasms, especially mucoepidermoid carcinoma and acinic cell carcinoma. Mucicarmine and periodic acid Schiff (PAS) staining were performed to assess the presence of mucous cells and PAS-positive glycogen-containing cells. Mucicarmine staining became negative and PAS staining was highly focally positive (Figures 4 and 5) . Therefore, these staining patterns did not prove conclusively an origin in the salivary gland. In searching for a diagnosis, we performed immunohistochemical staining for cytokeratin 7 (CK7). CK7 staining became negative, ruling out salivary gland origin. We began to suspect a metastatic clear-cell tumor such as RCC, and further investigated the patient's history. The patient was invited to the oral and maxillofacial department once again. On this occasion, the patient mentioned a history of nephrectomy after we asked him about his renal status. Inspection of his previous pathology report showed that the patient had had a radical nephrectomy 4 years previously and the diagnosis was RCC (clear-cell variant). To confirm a diagnosis of RCC which had metastasized to the tongue, we ordered immunohistochemical staining for CD 10 marker; CD10 is a good marker for RCC to distinguish it from other clear-cell-type carcinomas. Immunohistochemically, tumor cells were positive for CD10 (Fig.6 ). To complete the immunohistochemistry panel, Melan-A staining was performed in order to rule out clear-cell melanoma. Melan-A staining also became negative. Therefore, we made a diagnosis of clearcell tumor suggestive of "metastatic renal cell carcinoma".
Treatment and follow-up
A CT scan of the neck, chest, and abdomen revealed no other metastatic disease. Therefore, the patient underwent surgical re-excision of his lesion in order to provide comfort and prevent bleeding and infection. Afterwards, the patient was referred to an oncologist for systemic therapy. Subsequently, the patient was treated with sunitinib and sorafenib for his metastatic disease. The patient was still alive with no recurrence of his metastatic tongue lesion after 6 months of treatment.
Discussion
To the best our knowledge, this case report is the first in Iran to report RCC with tongue metastasis. (8), which make the diagnosis more complicated. In our case, incompleteness of the past medical history and unawareness of past radical nephrectomy and RCC clouded our diagnosis.
In this case, a clear-cell tumor was involved. Clear-cell tumors of the oral cavity include clear-cell variants of salivary gland neoplasms, clear-cell variants of odontogenic tumors (e.g. Pindborg tumor), primary and metastatic melanomas, and metastatic clear-cell carcinomas (e.g. RCC). Clear-cell variants of salivary gland neoplasms involve a broad spectrum, including mucoepidermoid carcinoma, acinic cell carcinoma, myoepithelial carcinoma, epithelial-myoepithelial carcinoma (double clear-cell variants) and clear-cell carcinoma. Histopathologic features such as mild pleomorphism and well-circumscription are more compatible with a low-grade mucoepidermoid carcinoma, acinic cell carcinoma and, to some extent, with clear-cell carcinoma, but not myoepithelial carcinoma and epithelialmyoepithelial carcinoma. The presence of cells similar to the mucous cells and even epithelioid cells in this case was suggestive of a low-grade mucoepidermoid carcinoma. Eccentrically located nuclei suggested a acinic cell carcinoma but not a clear-cell carcinoma. With respect to location, a Pindborg tumor was eliminated, while, according to a histopathologic view, clearcell melanoma was a remote diagnosis. Therefore, the most likely differential diagnoses included: 1) clear-cell variant of salivary gland neoplasms, especially mucoepidermoid carcinoma and acinic cell carcinoma; and 2) metastatic clear-cell variant of RCC. As stated before, we ultimately made a diagnosis of a metastatic RCC with respect to previous history of RCC, histopathologic features, and the immunohistochemical profile.
Because of different management approaches required for primary and metastatic cancers of the tongue, a comprehensive assessment to distinguish between them is essential.
Generally (8) followed surgical treatment of their patient by interferon-α, but due to increase of metastatic foci, they treated the patient again with targeted therapy using sunitinib and sorafenib (anti-VEGF agents). After surgical management, we treated the patient with sunitinib and sorafenib.
Basely et al. (9) suggested that F-18 fluorodeoxyglucose positron emission tomography (F-18 FDG PET), as an imaging modality, can be a useful tool in the follow-up of RCC.
Conclusion
Tongue metastasis from RCC is a rare condition. Differentiation among clearcell tumors can be challenging, and it can be especially difficult to distinguish between metastatic RCC and clear-cell tumors of the salivary glands. When encountering with a tongue lesion, a thorough evaluation should be made to distinguish between primary and metastatic cancers, as the management and prognosis vary.
